about
Control of cellular Bcl-xL levels by deamidation-regulated degradationChronoregulation by asparagine deamidation.Single-cell phenotyping within transparent intact tissue through whole-body clearingResistance to antineoplastic therapy. The oncogenic tyrosine kinase-Bcl-x(L) axis.Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination.Whole-body tissue stabilization and selective extractions via tissue-hydrogel hybrids for high-resolution intact circuit mapping and phenotyping.Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brainBetter Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.B.Cytokines and CNS development.Mapping a multiplexed zoo of mRNA expression.Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems.Corrigendum: Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.B.Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage.Global Representations of Goal-Directed Behavior in Distinct Cell Types of Mouse Neocortex.Viral Strategies for Targeting the Central and Peripheral Nervous Systems.The Neuropeptide Tac2 Controls a Distributed Brain State Induced by Chronic Social Isolation StressGene therapy for neurological disorders: progress and prospectsTRIM9-Mediated Resolution of Neuroinflammation Confers Neuroprotection upon Ischemic Stroke in MiceWhole brain delivery of an instability-prone Mecp2 transgene improves behavioral and molecular pathological defects in mouse models of Rett syndromeDelivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsidsSARS-CoV-2 is well adapted for humans. What does this mean for re-emergence?
P50
Q28534291-90417FDC-5040-4EC1-B5B7-7007483F166EQ30365377-CFD81928-5100-447B-AC36-A2E5E1363498Q34127451-AA23801F-8699-4234-9A3D-83E842725782Q35641609-5CC4B901-1FE6-4F2B-A1D1-43AB8875722EQ36580701-AF9313F5-CC87-49EF-A65E-B0875686E8C1Q37029369-0EE85DBA-8A72-4CD4-B3E4-7FF939FC1849Q37382030-FC00B32A-67EE-4B34-9086-F0C19F344E5DQ37393559-0EB787E7-3A50-4A51-8EF2-BBE06C13FBD2Q37617628-E2AB899F-0BA2-4B12-9378-EBA59797833EQ39323495-5A456F22-D660-4259-AF4C-EC16B1A62D03Q40137101-551987B2-ABE0-4C6F-8501-5A1BD8A319FCQ42344740-89D2ADA0-CFBC-4564-8E16-9977A57E55CAQ44173674-7E5E7AA3-8044-4CE1-AA6C-4D8D121C61F9Q47136920-1E071871-88BF-4901-AFE2-A7F82F461760Q52715648-15C84A24-B704-48E5-9CE0-91CDC9D90192Q56454994-FCFC71C9-86C2-42CA-9188-E7CC052F7BE1Q57165501-60387C86-5D20-41E5-A506-0940B49DEF62Q63740157-AA752915-D93D-41E1-86DB-FD54F6793904Q90619122-5A2F090A-B3E3-4CFB-A388-7E3C06DBE4F5Q91280013-8AE1BD4E-F962-41FE-ABD6-EC08B033ED1DQ95604838-EBBBEFDA-5F88-46A7-BCA3-29517ABAB457
P50
description
researcher ORCID ID = 0000-0002-6223-9303
@en
wetenschapper
@nl
name
Benjamin Deverman
@ast
Benjamin Deverman
@en
Benjamin Deverman
@es
Benjamin Deverman
@nl
type
label
Benjamin Deverman
@ast
Benjamin Deverman
@en
Benjamin Deverman
@es
Benjamin Deverman
@nl
prefLabel
Benjamin Deverman
@ast
Benjamin Deverman
@en
Benjamin Deverman
@es
Benjamin Deverman
@nl
P106
P31
P496
0000-0002-6223-9303